Paper13638009
Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid.
SUGIMURA T and 3 others. Arch Biochem Biophys, 1959. Cited by 158 papers, by iCite.
Cite this record
ConductScience Library. Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. Papers, record 13638009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13638009
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amino Acids | Major topic |
| Amino Acids, Essential | Major topic |
| Diet | Major topic |
| Food, Formulated | Major topic |
| Neoplasms | Major topic |
| Nitrogen | Major topic |
| Water | Major topic |
Source PubMed
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957232 | Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease. | In Vivo | 2026 | https://conductscience.org/library/papers/42957232 | PubMed |
| 42746398 | Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific. | Front Oncol | 2026 | https://conductscience.org/library/papers/42746398 | PubMed |
| 42665384 | The Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Inavolisib Has Breast-cancer Synergy Combined With Recombinant Methioninase But Not on Normal Cells. | In Vivo | 2026 | https://conductscience.org/library/papers/42665384 | PubMed |
| 42298579 | The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology. | Nutr Metab (Lond) | 2026 | https://conductscience.org/library/papers/42298579 | PubMed |
| 42078306 | The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts. | Cancer Diagn Progn | 2026 | https://conductscience.org/library/papers/42078306 | PubMed |
| 41760327 | Ultra-low Concentrations of Cisplatinum Down to the IC10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo. | In Vivo | 2026 | https://conductscience.org/library/papers/41760327 | PubMed |
| 41760305 | Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model. | In Vivo | 2026 | https://conductscience.org/library/papers/41760305 | PubMed |
| 41710278 | Methionine restriction in cancer: a dietary insight for therapy. | Front Nutr | 2026 | https://conductscience.org/library/papers/41710278 | PubMed |
| 41550357 | Methionine restriction for cancer therapy: From preclinical studies to clinical trials. | Cancer Pathog Ther | 2026 | https://conductscience.org/library/papers/41550357 | PubMed |
| 41487927 | Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal Cells. | Cancer Diagn Progn | 2026 | https://conductscience.org/library/papers/41487927 | PubMed |
| 41354708 | Catabolic rewiring in cancer impacts dietary interventions. | Commun Biol | 2025 | https://conductscience.org/library/papers/41354708 | PubMed |
| 41244132 | High plasma histidine concentration predicts a favorable prognosis in patients with ampullary cancer. | Am J Cancer Res | 2025 | https://conductscience.org/library/papers/41244132 | PubMed |
| 41008516 | Carboxy-Methylation of the Catalytic Subunit of Protein Phosphatase 2A (PP2Ac) Integrates Methionine Availability with Methionine Addicted Cancer Cell Proliferation. | Biomolecules | 2025 | https://conductscience.org/library/papers/41008516 | PubMed |
| 40900890 | Eradication of Extensive Lymph-Node, Bone and Pleural Metastases of a Breast-Cancer Patient Treated With Radiation, Immunotherapy and Oral Recombinant Methioninase. | Cancer Diagn Progn | 2025 | https://conductscience.org/library/papers/40900890 | PubMed |
| 40611418 | Recombinant Expression of L-methioninase from Brevibacterium linens and Evaluation of its Anticarcinogenic Properties against MiaPaCa-2 Cells. | Protein Pept Lett | 2025 | https://conductscience.org/library/papers/40611418 | PubMed |
| 40605016 | The role of B12 deficiency and methionine synthase in methionine-dependent cancer cells. | Cancer Metab | 2025 | https://conductscience.org/library/papers/40605016 | PubMed |
| 40430461 | Methionine Dependency and Restriction in Cancer: Exploring the Pathogenic Function and Therapeutic Potential. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430461 | PubMed |
| 40427696 | Targeting Methionine Metabolism Reveals AMPK-SAMTOR Signaling as a Therapeutic Vulnerability in Prostate Cancer. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40427696 | PubMed |
| 40141131 | Posttranslational Regulation of Mammalian Sulfur Amino Acid Metabolism. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141131 | PubMed |
| 39941872 | Targeting Methionine Addiction of Osteosarcoma with Methionine Restriction to Overcome Drug Resistance: A New Paradigm for a Recalcitrant Disease. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941872 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/13638009
GET https://conductscience.org/api/papers/v1/13638009/cited_by?page=2